Presbyopia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Presbyopia presents a widespread challenge affecting over a billion individuals globally. In developing regions, up to half of those aged 50 and above grapple with unmanaged presbyopia due to limited awareness and access to affordable treatment. Even in developed nations, the prevalence can reach as high as 34%. The definitions of presbyopia vary considerably, prompting a proposed redefinition: "Presbyopia arises when the natural age-related decline in the eye's focusing ability reaches a point where, despite optimal correction for distance vision, near vision clarity fails to meet individual needs." Various strategies exist for addressing presbyopia. These include the use of separate optical aids like reading glasses or the adoption of optical lenses with multiple focal points such as bifocal, trifocal, or progressive addition spectacles. Monovision techniques offer another approach, involving different corrections for each eye through methods like contact lenses, intraocular lenses, laser refractive surgery, or corneal collagen shrinkage. Simultaneous image correction, achieved via contact, intraocular, or corneal inlays, is also employed. Additional options include pinhole depth of focus expansion, intraocular lenses, corneal inlays, pharmaceuticals, and techniques like crystalline lens softening through lasers or pharmaceuticals. Additionally, strategies involving restored dynamics, such as 'accommodating' intraocular lenses, scleral expansion techniques, and ciliary muscle electrostimulation, are explored.
Thelansis’s “Presbyopia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Presbyopia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Presbyopia across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Presbyopia Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment